Although no specific RBP has been definitively identified as a biomarker of bone metastasis in HCC or CCA, RBPs such as IGF2BP1, HuR, LIN28, and FXR1 are known to be involved in promoting general metastasis and aggressive tumor behavior [95,96,97,98]. Here, ELAVL1 is linked to cholangiocarcinoma.